<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
    </SeriesInfo>
    <SeriesHeader>
      <EditorGroup>
        <Editor AffiliationIDS="Aff1">
          <EditorName DisplayOrder="Western">
            <GivenName>J.M.</GivenName>
            <FamilyName>Walker</FamilyName>
          </EditorName>
        </Editor>
        <Affiliation ID="Aff1">
          <OrgName>School of Life Sciences University of Hertfordshire</OrgName>
          <OrgAddress>
            <City>Hatfield</City>
            <State>Hertfordshire, AL10 9AB</State>
            <Country>UK</Country>
          </OrgAddress>
        </Affiliation>
      </EditorGroup>
    </SeriesHeader>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="Online" TocLevels="0">
        <BookID>978-1-60327-527-9</BookID>
        <BookTitle>T Cell Protocols</BookTitle>
        <BookSubTitle>Second Edition</BookSubTitle>
        <BookVolumeNumber>514</BookVolumeNumber>
        <BookSequenceNumber>514</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-527-9</BookDOI>
        <BookTitleID>145011</BookTitleID>
        <BookPrintISBN>978-1-58829-587-3</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-527-9</BookElectronicISBN>
        <BookChapterCount>11</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="SCL" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="SCL14005" Priority="1" Type="Secondary">Biochemistry, general</BookSubject>
          <BookSubject Code="SCB14000" Priority="2" Type="Secondary">Immunology</BookSubject>
          <BookSubject Code="SCL16020" Priority="3" Type="Secondary">Cell Culture</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor AffiliationIDS="Aff2">
            <EditorName DisplayOrder="Western">
              <GivenName>Gennaro</GivenName>
              <Particle>De</Particle>
              <FamilyName>Libero</FamilyName>
            </EditorName>
            <Role>Dr</Role>
            <Contact>
              <Email>Gennaro.DeLibero@unibas.ch</Email>
            </Contact>
          </Editor>
          <Affiliation ID="Aff2">
            <OrgName>University of Basel</OrgName>
            <OrgAddress>
              <State>Basel</State>
              <Country>Switzerland</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Chapter ID="Chap5" Language="En">
        <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="Online" TocLevels="0">
          <ChapterID>5</ChapterID>
          <ChapterNumber>Chapter 5</ChapterNumber>
          <ChapterDOI>10.1007/978-1-60327-527-9_5</ChapterDOI>
          <ChapterSequenceNumber>5</ChapterSequenceNumber>
          <ChapterTitle Language="En">Investigating T Cells by Polychromatic Flow Cytometry</ChapterTitle>
          <ChapterFirstPage>47</ChapterFirstPage>
          <ChapterLastPage>63</ChapterLastPage>
          <ChapterCopyright>
            <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
            <CopyrightYear>2009</CopyrightYear>
          </ChapterCopyright>
          <ChapterGrants Type="Regular">
            <MetadataGrant Grant="OpenAccess"/>
            <AbstractGrant Grant="OpenAccess"/>
            <BodyPDFGrant Grant="Restricted"/>
            <BodyHTMLGrant Grant="Restricted"/>
            <BibliographyGrant Grant="Restricted"/>
            <ESMGrant Grant="Restricted"/>
          </ChapterGrants>
          <ChapterContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-527-9</BookID>
            <BookTitle>T Cell Protocols</BookTitle>
          </ChapterContext>
        </ChapterInfo>
        <ChapterHeader>
          <AuthorGroup>
            <Author AffiliationIDS="Aff3" CorrespondingAffiliationID="Aff3">
              <AuthorName DisplayOrder="Western">
                <GivenName>Enrico</GivenName>
                <FamilyName>Lugli</FamilyName>
              </AuthorName>
            </Author>
            <Author AffiliationIDS="Aff3">
              <AuthorName DisplayOrder="Western">
                <GivenName>Leonarda</GivenName>
                <FamilyName>Troiano</FamilyName>
              </AuthorName>
            </Author>
            <Author AffiliationIDS="Aff3">
              <AuthorName DisplayOrder="Western">
                <GivenName>Andrea</GivenName>
                <FamilyName>Cossarizza</FamilyName>
              </AuthorName>
            </Author>
            <Affiliation ID="Aff3">
              <OrgDivision>Department of Biomedical Sciences</OrgDivision>
              <OrgName>Section of General Pathology</OrgName>
              <OrgAddress>
                <State>Modena</State>
                <Country>Italy</Country>
              </OrgAddress>
            </Affiliation>
          </AuthorGroup>
          <Abstract ID="Abs1" Language="En">
            <Heading>Abstract</Heading>
            <Para TextBreak="No">Since its development, flow cytometry gave a relevant contribution to the field of Immunology. Its unique potential to analyse multiple parameters at the single cell level allowed the identification of unknown cell subsets with specific roles in immunoregulation as well as in the pathogenesis of several diseases. More recently, with the advent of new equipments and fluorochromes, the possibility exists to analyse simultaneously a large number (up to 19) of parameters in a single cell. This strategy, defined polychromatic flow cytometry (PFC), has been widely utilised in the last years for the fine analysis of immune cell phenotypes, including antigen-specific T lymphocytes, B cell subsets, and the intracellular phosphoproteome, among others. A huge amount of data can be generated by such an approach, and their interpretation could become a very complex and time-consuming task. Protocols for performing PFC will be discussed in this chapter, together with some guidelines for data interpretation and analysis.</Para>
          </Abstract>
          <KeywordGroup Language="En">
            <Heading>Key words</Heading>
            <Keyword>Polychromatic flow cytometry</Keyword>
            <Keyword>monoclonal antibodies</Keyword>
            <Keyword>fluorescence compensation</Keyword>
            <Keyword>single stained controls</Keyword>
            <Keyword>fluorescence-minus-one controls</Keyword>
            <Keyword>surface antigens</Keyword>
            <Keyword>intracellular antigens</Keyword>
            <Keyword>data analysis</Keyword>
            <Keyword>cluster analysis</Keyword>
          </KeywordGroup>
        </ChapterHeader>
        <Body>
          <Section1 ID="Sec1" OutputMedium="Online" Type="Introduction">
            <Heading>Introduction</Heading>
            <Para TextBreak="No">Fluorescence-activated flow cytometry is the powerful technology that allows the analysis of the fluorescence emitted by cells in suspension that have been previously stained with fluorescent probes or fluorochrome-conjugated monoclonal antibodies (mAbs). Cells are conveyed in the flow chamber through a capillary which ensures the transition on a cell-by-cell basis and, thus, allows single cell analysis of light scatter and fluorescent signals. At the end of 1960s, the first commercial flow cytometer, i.e. the “Impulsecytophotometer ICP-11”, developed in 1968 by Dr. Wolfgang Göhde/Partec and distributed by Phywe AG, Göttingen, had optionally one or two fluorescence parameters for the analysis of DNA content and ploidy. Scatter parameters were not featured by this instrument.</Para>
            <Para TextBreak="No">The technology knew a rapid growth during the next years, that became exponential in the era of HIV infection. Indeed, at the end of 1980s tools capable of measuring up to four colours were developed. In the last years, flow cytometry has been characterised by further improvements, that are giving the possibility to measure simultaneously up to 19 parameters in the same cell <CitationRef CitationID="CR1">(1</CitationRef>, <CitationRef CitationID="CR2">2)</CitationRef>. However, along with the increase in the number of parameters that can be measured, experiments and data analysis are becoming more complex. Post-acquisition computer assistance is required to minimise possible errors thanks to the generation of a compensation matrix, and to reduce the complexity of huge data-sets generated by such a technology. We will briefly illustrate the steps that we follow for an adequate use of polychromatic flow cytometry (PFC), and indicate how to perform analysis of these data either by conventional or new, original approaches.</Para>
          </Section1>
          <Section1 ID="Sec2" OutputMedium="Online">
            <Heading>Materials</Heading>
            <Para TextBreak="No">
              <OrderedList>
                <ListItem>
                  <ItemNumber>1.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Fresh (better!) or cryopreserved peripheral blood mononuclear cells (PBMCs);</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>2.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Phosphate buffer saline (PBS), store at 4°C;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>3.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Foetal Bovine Serum (FBS), store at –20°C;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>4.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Staining buffer: PBS + 0.5% Bovine Serum Albumin (BSA), store at 4°C; an alternative staining buffer can be used in order to avoid cell loss during centrifugation: PBS + 5% FBS, which can be stored at 4°C for up to 1 month;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>5.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Fluorochrome-conjugated monoclonal antibodies;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>6.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">BD™ CompBeads (BD Biosciences, Franklin Lakes, NJ, USA);</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>7.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Viability dye, such as propidium iodide (PI), stock solution at the concentration of 50 μg/mL in PBS, store at 4°C, stable for years;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>8.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">“Monomeric cyanine nucleic acid stains” dyes (Invitrogen Corp. Carlsbad, CA, USA), such as TO-PRO3, stock solution at 1 mM in DMSO, store at –20°C, stable for up to 1 year.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>9.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Fixable viability dyes, such as “LIVE/DEAD fixable dead cell stain kits” (Invitrogen); once dissolved in DMSO, they are stable for 15 days at –20°C. Caution: DMSO is toxic; avoid ingestion and inhalation or contact with eyes and skin;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>10.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Paraformaldehyde (PFA), 1% in PBS, pH 7.2, or an equivalent fixation buffer. PFA (1%) in PBS can be stored at 4°C for up to 1 month. Caution: PFA is irritant; avoid ingestion and inhalation or contact with eyes and skin;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>11.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Tween 20 (0.2%) in PBS, pH 7.2, or an equivalent permeabilisation buffer. Tween 20 (0.2%) in PBS can be stored at 4°C for up to 1 month. Caution: Tween 20 is toxic; avoid ingestion and inhalation or contact with eyes and skin;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>12.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Three laser (405, 488 and 635 nm) flow cytometer;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>13.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Software for compensation and data analysis;</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>14.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Softwares for cluster analysis, such as Cluster and Treeview softwares (downloadable at <ExternalRef>
                        <RefSource>rana.lbl.gov</RefSource>
                        <RefTarget Address="http://rana.lbl.gov" TargetType="URL"/>
                      </ExternalRef>) or TM4 MeV (downloadable at <ExternalRef>
                        <RefSource>www.tm4.org/mev.html</RefSource>
                        <RefTarget Address="http://www.tm4.org/mev.html" TargetType="URL"/>
                      </ExternalRef>) or similar</Para>
                  </ItemContent>
                </ListItem>
              </OrderedList>
            </Para>
          </Section1>
          <Section1 ID="Sec3" OutputMedium="Online">
            <Heading>Methods</Heading>
            <Para TextBreak="No">The methods described here below refer to the possibility of performing a PFC analysis on peripheral blood lymphocytes. We will briefly describe: (1) the set up of the flow cytometer; (2) how to choose the right fluorochromes; (3) the procedure to correctly compensate fluorescence spillover among different channels; (4) some tricks to avoid the detection of unspecific, false positive events; (5) the protocol for a simultaneous detection of T cell surface markers along with intracellular Ki-67 expression by fluorochrome-labelled mAbs; and (6) how to perform data analysis by classical and recently developed methodologies.</Para>
            <Section2 ID="Sec4" OutputMedium="Online">
              <Heading>Set Up of the Flow Cytometer</Heading>
              <Para TextBreak="No">Currently, the most sophisticated flow cytometers available on the market are already equipped with filters and dichroic mirrors for the detection of several fluorochromes. <Emphasis Type="Bold">Table</Emphasis>
                <InternalRef RefID="Tab5_1_978-1-60327-527-9">
                  <Emphasis Type="Bold">5.1</Emphasis>
                </InternalRef> shows the most common fluorochromes employed in the polychromatic analysis of lymphocyte phenotype, the laser line used for their excitation and the suggested wavelength of filters for their detection. Multiparameter flow cytometers that can detect eight colours or more are generally equipped with a blue laser that has a wavelength of 488 nm, a 635 nm red laser and a 405 nm violet laser; other lasers could also be used, such as a 350 nm UV laser for better excitation of fluorochromes such as Hoechst 33342 (for DNA content), monobromobimane (for intracellular reduced glutathione) and Indo-1 (for quantification of intracellular free or protein-bound calcium), which are often used for functional studies of T cells, or a 532 nm green laser for better excitation of propidium iodide, PE-tandems or merocyanine 540.
<Table Float="Yes" ID="Tab5_1_978-1-60327-527-9">
                  <Caption Language="En">
                    <CaptionNumber>Table 5.1</CaptionNumber>
                    <CaptionContent>
                      <SimplePara>Fluorochromes that are commonly used in polychromatic flow cytometry, with their excitation wavelength (λ) and suggested filter used for their detection</SimplePara>
                    </CaptionContent>
                  </Caption>
                  <tgroup cols="3">
                    <colspec align="left" colname="col1" colnum="1"/>
                    <colspec align="left" colname="col2" colnum="2"/>
                    <colspec align="left" colname="col3" colnum="3"/>
                    <thead>
                      <row>
                        <entry colname="col1" valign="top">
                          <SimplePara>Laser excitation</SimplePara>
                        </entry>
                        <entry colname="col2" valign="bottom">
                          <SimplePara>Fluorochrome (Abbreviation)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>λ of the filter used for detection (expressed in nm)</SimplePara>
                        </entry>
                      </row>
                    </thead>
                    <tbody>
                      <row>
                        <entry colname="col1" valign="top">
                          <SimplePara>488 nm (blue laser)</SimplePara>
                        </entry>
                        <entry colname="col2" valign="top">
                          <SimplePara>Fluorescein (FITC)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>510–530</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Alexa 488</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>510–530</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Phycoerythrin (PE)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>565–590</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Phycoerythrin-Texas Red (PE-TxR, ECD)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>600–620</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Phycoerythrin-cyanine 5 (PE-Cy5, or Tricolour, TC)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>650–680</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Perchlorophilin (PerCP)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>650–680</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Phycoerythrin-cyanine 5.5 (PE-Cy5.5)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>690–730</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Perchlorophilin-cyanine 5.5 (PerCP-Cy5.5)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>690–730</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Phycoerythrin-cyanine 7 (PE-Cy7, PC7)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>750 long pass</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top">
                          <SimplePara>633 nm (red laser)</SimplePara>
                        </entry>
                        <entry colname="col2" valign="top">
                          <SimplePara>Allophycocyanine (APC)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>650–670</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Alexa 647</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>650–670</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Allophycocyanine-cyanin 5.5 (APC-Cy5.5)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>690–730</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Alexa 700</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>690–730</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Allophycocyanine–cyanin 7 (APC-Cy7)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>750 long pass</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Allophycocyanine-Alexa750 (APC-Alexa750)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>730 long pass</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top">
                          <SimplePara>404 nm (violet laser)</SimplePara>
                        </entry>
                        <entry colname="col2" valign="top">
                          <SimplePara>Cascade Blue (CB)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>435–475</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Pacific Blue (PB)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>435–475</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Alexa 405</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>435–475</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Cascade Yellow (CY)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>530–570</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="col1" valign="top"/>
                        <entry colname="col2" valign="top">
                          <SimplePara>Pacific Orange (PO)</SimplePara>
                        </entry>
                        <entry colname="col3" valign="top">
                          <SimplePara>530–570</SimplePara>
                        </entry>
                      </row>
                    </tbody>
                  </tgroup>
                </Table>
              </Para>
              <Para TextBreak="No">The choice of filters and mirrors is aimed both to detect the brightest signal of the fluorochrome and to minimise the fluorescence compensation among different channels. Different types of filters and mirrors are typically present in a flow cytometer. Dichroic mirrors are able to reflect the fluorescence below a given wavelength and to transmit the fluorescence with a higher wavelength, or vice versa. In general, dichroic mirrors have a wavelength that is in the middle of two strategical fluorescence channels. For example, for the detection of FITC (maximum emission at 520 nm) an PE (maximum emission at 590 nm), a 560 nm dichroic mirror should be adopted. The sequential introduction of dichroic mirrors in the optical setting allows an optimal separation and detection of multiple fluorochromes at the same time. Since in a polychromatic configuration the light arriving from fluorochromes to photomultipliers (PMT) is selected through several mirrors, it is extremely important to check carefully the transmission power of mirrors in order to avoid loss of fluorescence <CitationRef CitationID="CR3">(3)</CitationRef>.</Para>
              <Para TextBreak="No">Filters in front of the PMT are equally important and further collect the light transmitted or reflected by dichroics. These filters can be either band-pass (collecting the light between two specific wavelengths) or long-pass (collecting the light higher than a specific wavelength). The choice of filters depends upon the emission wavelength of the fluorochrome that has to be measured. These filters should be wide enough to collect the maximum light arriving from the excited fluorochrome (<Emphasis Type="Bold">Table</Emphasis>
                <InternalRef RefID="Tab5_1_978-1-60327-527-9">
                  <Emphasis Type="Bold">5.1</Emphasis>
                </InternalRef>).</Para>
              <Para TextBreak="No">Note: Most flow cytometers now have a fixed configuration and there is no need to work on the hardware. However, in several instruments the possibility exists to change the configuration according to the requirement of the user.</Para>
            </Section2>
            <Section2 ID="Sec5" OutputMedium="Online">
              <Heading>Choose the Right Fluorochrome</Heading>
              <Para TextBreak="No">A variety of fluorochromes can be used to detect antigens by PFC, and thus thousands of combinations are literally possible. However, not all fluorochromes are suitable for the detection of certain antigens. Indeed, there are two main aspects that should be considered when choosing a particular antibody-conjugate: (i) the brightness of the fluorochrome and the relative abundance of the antigen of interest; (ii) the requirements of the fluorescence compensation among different channels.</Para>
              <Section3 ID="Sec6" OutputMedium="Online">
                <Heading>Brightness of the Fluorochrome and Amount of Antigen</Heading>
                <Para TextBreak="No">Not all the fluorochromes have the same brightness; as a consequence, those brighter than others, such as PE, PE-Cy5, PE-Cy7 and APC, should be adopted for the detection of antigens which have low expression (such as cytokines, chemokines and their receptors), or for rare events (intracellular cytokines in antigen-specific assays, or intracellular Ki-67 in unstimulated lymphocytes). For example, only PE-conjugated mAbs are suitable for the detection of the expression of CD127 (the IL-7 receptor α-chain) on CD3+ T cells, while APC-conjugated mAbs are not.</Para>
                <Para TextBreak="No">It is suggested to adopt APC-tandem dyes for the detection of well-expressed lineage antigens, i.e. CD3, CD4, CD8, where a good and clear separation exists between negative and positive populations. Be careful with certain violet dyes, mainly with Cascade Blue or similar (Pacific Blue and Alexa 405) which can bind in a non-specific manner to dead cells <CitationRef CitationID="CR4">(4)</CitationRef> and Lugli et al., unpublished observation). This implies that these dyes can be used not only for the detection of certain markers but also provide a good tool for excluding dead cells from the analysis <CitationRef CitationID="CR4">(4)</CitationRef>. Finally, take into account that tandem fluorochromes tend to degrade faster (the acceptor fluorochrome can detach from the donor and thus the signal is lost), sometimes before the expiration date indicated in the label.</Para>
              </Section3>
              <Section3 ID="Sec7" OutputMedium="Online">
                <Heading>Compensation Requirements Among Different Channels</Heading>
                <Para TextBreak="No">It is important to consider the interference of other fluorochromes into the channel of interest (<Emphasis Type="Italic">see</Emphasis>
                  <Emphasis Type="Bold">Section</Emphasis>
                  <InternalRef RefID="Sec8">
                    <Emphasis Type="Bold">3.3</Emphasis>
                  </InternalRef>). In fact, the dyes or probes used in PFC can have wide emission spectra, and their fluorescence can be detected in different channels <CitationRef CitationID="CR5">(5)</CitationRef>. In some cases, this interference is relevant, and thus the detection of certain antigens is almost impossible. This is the case for the probe Carboxyfluorescein Diacetate-Succinimidyl Ester (CFSE), commonly used to detect clonal proliferation of T cells. CFSE, which is typically detected in the FITC channel, has a very broad emission spectrum and displays a considerable spillover into PE and PE-Cy5 channels. Hence, it is very difficult to detect antigens with a low expression in these channels, even if antibodies conjugated to bright fluorochromes are used. <Emphasis Type="Bold">Figure</Emphasis>
                  <InternalRef RefID="Fig5_1_978-1-60327-527-9">
                    <Emphasis Type="Bold">5.1</Emphasis>
                  </InternalRef> shows that PE anti-CD127 mAb is not suitable for the detection of CD127 expression when used with CFSE. In fact, in the case shown here, 57% of peripheral blood lymphocytes express CD127; however, in cells co-stained with CFSE (and after proper compensation), CD127+ cells are mostly undetectable. Thus, in this case, it is recommended to analyse CD127 (or antigens with low expression) in other channels, where the spillover of CFSE is minimal, such as in channels collecting light from violet fluorochromes. PE and PE-tandems can be utilised, but only for recognising brighter antigens, such as lineage molecules such as CD3, without a relevant loss of sensitivity.
<Figure Category="Standard" Float="Yes" ID="Fig5_1_978-1-60327-527-9">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 5.1.</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Effect of the fluorescence spillover on the detection of antigens with low expression.</SimplePara>
                        <SimplePara>PBMCs were stained either with anti-CD127 PE, CFSE or both, then samples were compensated with FlowJo 6.3 for MacOSX. Percentages are given for CD127+ lymphocytes within the gate. In <Emphasis Type="Italic">lower right panel</Emphasis>, the staining with CFSE and PE-Cy7 CD3 is shown for a comparison. Note that CD3+ cells are easily recognisable.</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject>
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_5_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                    </MediaObject>
                  </Figure>
                </Para>
              </Section3>
            </Section2>
            <Section2 ID="Sec8" OutputMedium="Online">
              <Heading>Fluorescence Compensation in PFC</Heading>
              <Para TextBreak="No">Fluorochromes commonly used in polychromatic experiments display spectral overlap <CitationRef CitationID="CR5">(5)</CitationRef>. As a consequence, a particular fluorochrome can be measured in multiple PMTs. These signals are to be eliminated by a process called compensation, which is able to mathematically subtract the unwanted fluorescence in a specific detector <CitationRef CitationID="CR6">(6)</CitationRef>. In PFC, compensation requirements are very complex because the emission of each fluorochrome is to be subtracted from all the channels and the number of pair-wise combinations grows exponentially with the number of parameters measured. Nowadays, compensation can be automatically performed by dedicated softwares which are able to simplify the procedure and minimise errors. In order to compensate correctly, samples stained with single fluorochromes are prepared. When compensating, consider the following aspects:<UnorderedList Mark="Dash">
                  <ItemContent>
                    <Para TextBreak="No">For single stained samples, employ either the cells that will be used in the experiment or CompBeads™. CompBeads™ are beads which are able to bind light chain-bearing immunoglobulins, display a very high fluorescence in the channel of interest and provide both positive and negative signals which can be used to perform multicolour compensation. Since the antibodies used for compensation are the same as the ones used for the assays, artefacts due to reagents variability are avoided.</Para>
                  </ItemContent>
                  <ItemContent>
                    <Para TextBreak="No">When performing compensation, always gate in the population of interest. In fact, different autofluorescence values, which generally characterise different cell populations (such as lymphocytes and monocytes), can influence compensation.</Para>
                  </ItemContent>
                  <ItemContent>
                    <Para TextBreak="No">Use a compensation control that is at least as bright as the antibody used in the assay, i.e. the antibodies chosen for the staining panel, or antibodies recognising a very bright antigen, i.e. CD8. However, different antibodies, even if conjugated to the same fluorochrome and produced by the same company, can display different characteristics (see below).</Para>
                  </ItemContent>
                  <ItemContent>
                    <Para TextBreak="No">Always use the same antibodies chosen for the staining of interest. Be careful especially to tandem dyes which can behave very differently not only from company to company, but also from lot to lot <CitationRef CitationID="CR7">(7)</CitationRef>. In tandem dyes, two molecules are chemically conjugated (for example, PE to Cy5), but the efficiency of the conjugation reaction can be very variable, and, thus, affect compensation in a different way. For this reason, compensation matrix should always be checked when using different conjugates.</Para>
                  </ItemContent>
                  <ItemContent>
                    <Para TextBreak="No">Be always sure that your instrument has a correct laser alignment. Check this by running rainbow beads and ensure that the performance of the cytometer is the same day by day <CitationRef CitationID="CR3">(3)</CitationRef>. An improper alignment of the lasers and alterations in their time delays could influence compensation.</Para>
                  </ItemContent>
                </UnorderedList>
              </Para>
            </Section2>
            <Section2 ID="Sec9" OutputMedium="Online">
              <Heading>Use of a Dump Channel to Exclude Unspecific Events</Heading>
              <Section3 ID="Sec10" OutputMedium="Online">
                <Heading>Exclusion of Dead Cells</Heading>
                <Para TextBreak="No">Frozen cells are commonly (and unfortunately) utilised in a large amount of immunological researches. Freezing and thawing procedures cause cell rupture and death, often relevant. When performing multicolour experiments starting from frozen cells, the following aspects should be considered: (i) antibodies like dead cells and debris, leading to unspecific positive events; (ii) certain antigens can be altered on dead cells, and false negative/dim cell population can appear in the population of interest; (iii) dead cells are characterised by a higher autofluorescence and can generate false positive signals, or can affect compensation. The inclusion of dead cells in the analysis is particularly harmful when analysing rare subsets. For this reason, a dye able to track dead cells is to be included (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5_2_978-1-60327-527-9">
                    <Emphasis Type="Bold">5.2</Emphasis>
                  </InternalRef>). When performing surface immunophenotyping, dyes such as PI (excited by a 488 nm laser and emitting in the PE-TxR channel) or similar (i.e. monomeric cyanine nucleic acid stains) can be used.
<Figure Category="Standard" Float="Yes" ID="Fig5_2_978-1-60327-527-9">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 5.2.</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Analysis of Ki-67+ T cells by polychromatic flow cytometry.</SimplePara>
                        <SimplePara>PBMCs were simultaneously stained with LIVE/DEAD blue to identify dead cells and several mAbs to quantify the expression of CD3, CD4, CD8, CD14, Ki-67, CD45RA and CCR7. (<Emphasis Type="Bold">a</Emphasis>) The presence of dead cells can influence the analysis of rare subsets. The percentage of Ki-67+ lymphocytes before (<Emphasis Type="Italic">left</Emphasis>) and after (<Emphasis Type="Italic">right</Emphasis>) gating on live/CD14- cells is indicated. Note that without the gate on CD14- living cells the percentage of false positive Ki-67+ cells is more than double. (<Emphasis Type="Bold">b</Emphasis>) Further analysis of the characteristics of Ki-67+ T cells. Dead cells and monocytes were excluded as in (a), then lymphocytes were identified by gating on forward (FSC) and side scatter (SSC), and T cells on the basis of CD3 expression; helper and cytotoxic subsets of T cells were then selected by CD4 and CD8 positivity, respectively. The percentages of proliferating Ki-67+ CD4+ and CD8+ T cells are indicated. Inside Ki-67+ cells, further analysis of CD45RA and CCR7, which define T cell differentiation status, are shown. Numbers indicate the percentage of cells inside the gate.</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject>
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_5_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                    </MediaObject>
                  </Figure>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Resuspend cells in staining buffer;</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Stain cell surface antigens with fluorescent-labelled mAbs (see below);</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Wash with 2 mL of staining buffer at 300 <Emphasis Type="Italic">g</Emphasis> for 5 min;</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Resuspend cells in staining buffer;</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Add 1 μg/mL PI or 2 nM TO-PRO3 or equivalent dye to the cell suspension, mix thoroughly and analyse on cytometer;</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Exclude dead cells by gating PI or TO-PRO3 negative cells on SSC vs PI/TO-PRO3 dot plot;</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
                <Para TextBreak="No">Generally, propidium iodide is chosen. Also, TO-PRO 3 works very well in our hands; however, since this dye is excited by the 635 nm red laser and emits around 660 nm, it is not possible to include APC-conjugated antibodies in the staining.</Para>
                <Para TextBreak="No">Differently, when performing analysis on permeabilised samples, it is necessary to stain dead cells before the permeabilisation step, in order to avoid the staining of the whole cell population. Traditionally, ethidium monoazide (EMA), a fixable dye that enters dead cells and covalently links to DNA after light exposure, has been used for this purpose. However, recently, the LIVE/DEAD family dyes have become available: they are ready to use, display very high fluorescence and can be excited with different lasers, facilitating the application in multicolour experiments. The staining protocol for LIVE/DEAD dyes will be described in <Emphasis Type="Bold">Section</Emphasis>
                  <InternalRef RefID="Sec12">
                    <Emphasis Type="Bold">3.5</Emphasis>
                  </InternalRef>.</Para>
              </Section3>
              <Section3 ID="Sec11" OutputMedium="Online">
                <Heading>Exclusion of Non-T Cells</Heading>
                <Para TextBreak="No">When performing PFC analysis of T cells, markers for the identification of major T cell subsets, such as CD4 and CD8, in addition to the <Emphasis Type="Italic">pan</Emphasis> T cell marker CD3, are included. Moreover, to exclude non-T cells from analysis, anti-CD19, anti-CD56 and anti-CD14 mAbs can be assigned to a “dump” channel (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5_2_978-1-60327-527-9">
                    <Emphasis Type="Bold">5.2a</Emphasis>
                  </InternalRef>). This procedure partially reduces fluorescence background derived from the non-specific binding of mAbs to cell types other than T cells, mainly monocytes. In order to save another channel for the antigens of interest, these mAbs can be included in the channel used for the identification of dead cells.</Para>
              </Section3>
            </Section2>
            <Section2 ID="Sec12" OutputMedium="Online">
              <Heading>Analysis of T Cell Phenotype and Intracellular Antigens by Fluorescent-Labelled Monoclonal Antibodies</Heading>
              <Para TextBreak="No">A simple protocol to analyse T cell surface phenotype together with intracellular antigens is described below. In particular, we present a 8-colour assay for the identification of the differentiation status <CitationRef CitationID="CR8">(8)</CitationRef> of proliferating CD3+,CD4+ or CD3+,CD8+T cells, i.e. those expressing Ki-67 (<Emphasis Type="Bold">Fig.</Emphasis>
                <InternalRef RefID="Fig5_2_978-1-60327-527-9">
                  <Emphasis Type="Bold">5.2b</Emphasis>
                </InternalRef>). Note that staining with LIVE/DEAD blue has been added to identify dead cells, and anti-CD14 mAb to exclude monocytes from the gate of analysis.<OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Resuspend 1×10<Superscript>6</Superscript> peripheral blood mononuclear cells (PBMCs, previously isolated by Ficoll density gradient centrifugation) in 100 μL of staining buffer;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Add mAbs for surface markers at the pre-titrated concentrations. Always titrate antibodies before use. For detailed antibody titration procedures consult the paper by Kantor and Roederer <CitationRef CitationID="CR9">(9)</CitationRef>;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Incubate for 20 min at room temperature (RT). Note that some antigens, such as chemokine receptors, are better recognised by incubation with mAbs at 37°C;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Wash at 300 <Emphasis Type="Italic">g</Emphasis> for 5 min at RT with staining buffer. In order to avoid cell loss, washing steps can be performed with PBS + 10% FBS;</Para>
                      <Para TextBreak="No">Note: It is possible to avoid dead cell staining (steps 5–10) if working with freshly isolated cells</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Wash with PBS;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Resuspend the cells in 1 mL of PBS;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Adjust the cell density to 1×10<Superscript>6</Superscript> cells/mL;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Add 1 μL/10<Superscript>6</Superscript> cells of the LIVE/DEAD fixable dead cell stain solution;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>9.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Incubate for 30 min at room temperature (RT);</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>10.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Wash with PBS;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>11.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Resuspend cells in 1 mL of PBS + 1% PFA or equivalent fixation buffer;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>12.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Incubate 15 min at RT;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>13.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Wash with staining buffer;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>14.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Wash with 2 mL of PBS + 0.2% tween 20 or equivalent permeabilisation buffer;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>15.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Resuspend cells in 100 μL of PBS + 0.2% tween 20 or equivalent permeabilisation buffer;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>16.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Add anti-Ki67 monoclonal antibody;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>17.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Mix thoroughly and incubate for 30 min at 4°C;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>18.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Wash with staining buffer;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>19.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Resuspend cells in 1 mL of PBS + 1% PFA;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>20.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Prepare compensation controls using single-stained compensation controls or CompBeads™;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>21.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Acquire compensation controls on flow cytometer;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>22.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Analyse samples on flow cytometer within 24 h;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>23.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Acquire at least 300,000 events;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>24.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Create compensation matrix by software;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>25.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Compensate experimental samples;</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>26.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Analyse samples as described below.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
            <Section2 ID="Sec13" OutputMedium="Online">
              <Heading>Data Analysis</Heading>
              <Section3 ID="Sec14" OutputMedium="Online">
                <Heading>How to Set the Gates: “Fluorescence Minus One” Controls</Heading>
                <Para TextBreak="No">During the analysis of the data, it is obviously crucial to distinguish the presence or not of the antigen of interest. This is very simple when investigating antigens whose positive expression is clearly distinguishable from the background fluorescence, i.e. CD3, CD4, CD5, CD8, etc. However, in most cases, antigens with unknown patterns of expression are investigated, and it is difficult to set the threshold of positivity. Unstained samples, or those incubated with irrelevant mAbs of the same isotype and colour, are absolutely not reliable for this purpose. “Fluorescence minus one” (FMO) controls must be utilised <CitationRef CitationID="CR1">(1)</CitationRef>. FMO controls are samples that have been stained with all antibodies except the one of interest. When performing multicolour experiments, in addition to single stained samples, prepare FMO controls for all the antigens under investigation, then set the gates to distinguish positive and negative expression and analyse data as described below.</Para>
              </Section3>
              <Section3 ID="Sec15" OutputMedium="Online">
                <Heading>Conventional Methods for the Analysis of Flow Cytometric Data</Heading>
                <Para TextBreak="No">The most common method for the analysis of flow cytometric data is the use of histograms, if only one parameter has to be visualised. Histograms are very useful when the same antigen is to be analysed through multiple experimental samples, such as when studying its frequency or the grade of positivity (in terms of fluorescence intensity – that must be calculated and expressed in a linear scale). Almost all softwares provide tools for the overlay of histograms from multiple samples, allowing a rapid analysis of the parameter(s) of interest.</Para>
                <Para TextBreak="No">Differently, when there is the need to visualise two parameters simultaneously, multiple choices are available. Historically, <Emphasis Type="Italic">dot plots</Emphasis> are the most common graph used for this purpose (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5_3_978-1-60327-527-9">
                    <Emphasis Type="Bold">5.3</Emphasis>
                  </InternalRef>). In this type of representation, each singe event is depicted as a <Emphasis Type="Italic">black dot</Emphasis> on the screen. However, monochrome dot plots have many limitations, the first of which is due to the fact that cells displaying the same amounts of fluorescences occupy the same area on the plot and cannot be further distinguished. In fact, when the acquisition of a high number of cells is required, even low cell density-areas are saturated by a consistent number of events, leading to a difficult identification of cellular subsets <CitationRef CitationID="CR10">(10)</CitationRef>. These hurdles can be overcome by the use of contour plots. In this case, contours identify regions with variable cell density and the representation obtained is irrespective of the number of acquired events (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5_3_978-1-60327-527-9">
                    <Emphasis Type="Bold">5.3</Emphasis>
                  </InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig5_3_978-1-60327-527-9">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 5.3.</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Cellular subsets are better defined by contour plots rather than dot plots.</SimplePara>
                        <SimplePara>Different numbers of events related to the expression of CD45R0 and CCR7 are visualised in two different ways, as dot plots (<Emphasis Type="Italic">top</Emphasis>) or 5% probability contour plots plus outliers. Note that, in the contour plot representation, the increasing number of events still allows an easy recognition of cellular subsets.</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject>
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_5_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                    </MediaObject>
                  </Figure>
                </Para>
              </Section3>
              <Section3 ID="Sec16" OutputMedium="Online">
                <Heading>New Tools for the Analysis of PFC Data</Heading>
                <Para TextBreak="No">The procedures described above are useful when analysing specific subsets and can be utilised when performing multiple, sequential gates, as shown in <Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5_2_978-1-60327-527-9">
                    <Emphasis Type="Bold">5.2</Emphasis>
                  </InternalRef>. However, in PFC, when several antigens are detected at the same time in a single cell, classical methods of analysis are difficult to employ as they do not consider the flow cytometric output as a whole. In other words, the use of 8 mAbs to stain typically 100 µL of blood gives origin to 256 (=2<Superscript>8</Superscript>) cell subpopulations, not to mention the possibility to add other parameters such as the physical scatters (reaching the number of 1,024 subsets). Methods have been developed to identify subsets that differ among samples, i.e. Probability Binning Comparison <CitationRef CitationID="CR11">(11)</CitationRef> or algorithms for the automatic identification of subsets <CitationRef CitationID="CR1">(1)</CitationRef>. Here we describe the procedure to perform Cluster Analysis, an approach we recently used to identify the dynamics of T cell subsets during the ageing of the immune system, and to cluster subjects with similar immunophenotypes <CitationRef CitationID="CR12">(12)</CitationRef>.<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Identify the main subset to be analysed (i.e. CD4+ or CD8+ T cells, CD19 + B cells, CD56+ NK cells, etc.);</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Inside this gate, plot all parameters vs FSC or SSC , or use histograms (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig5_4_978-1-60327-527-9">
                            <Emphasis Type="Bold">5.4</Emphasis>
                          </InternalRef>
                          <Emphasis Type="Bold">a</Emphasis>);
<Figure Category="Standard" Float="Yes" ID="Fig5_4_978-1-60327-527-9">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 5.4.</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>Subjects of different age can be clustered on the basis of the flow cytometric phenotype.</SimplePara>
                                <SimplePara>(<Emphasis Type="Bold">a</Emphasis>) PBMCs from a representative donor were stained with eight different mAbs to analyse the expression of CD3, CD4, CD8, CD45RA, CCR7, CD127, CD95 and CD38. Positive and negative expression of antigens is indicated in the histograms. (<Emphasis Type="Bold">b</Emphasis>) All possible phenotypes were generated as described in <Emphasis Type="Bold">Section 3.6.3.</Emphasis> T cell subpopulations were clustered by using “complete linkage” and “correlation similarity” as parameters. Cluster analysis identifies two branches: the one on the left mainly contained young donors, that on the right mainly centenarians. Note that middle-age donors are scattered between the two groups, indicating a high heterogeneity of this group. The grey scale of variables (cell populations) ranges from white (for log ratios of ≤3.0) to black (for log ratios of ≥3.0).</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_5_Fig4a_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_5_Fig4b_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Identify the threshold of positivity for each antigen analysed, in order to generate two subsets, positive and negative (for example, for CD45R0 antigen identify CD45R0+ and CD45R0- cells). In some cases, positive expression can be further distinguished between <Emphasis Type="Italic">dim</Emphasis> and <Emphasis Type="Italic">bright</Emphasis>, in order to identify cellular subsets with different biological function (for example, CD25 <Emphasis Type="Italic">dim</Emphasis> expression identifies conventional activated CD4+ T cells, while CD25 <Emphasis Type="Italic">bright</Emphasis> expression identifies regulatory T cells);</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">By using a software like FlowJo (Treestar, Ashland, OR, USA), combine positive and negative gates in order to generate all the possible phenotypes/combinations of antigens (typically 2<Superscript>
                            <Emphasis Type="Italic">n</Emphasis>
                          </Superscript>, where <Emphasis Type="Italic">n</Emphasis> is the number of analysed parameters);</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Generate a .txt table file which contains all the possible subsets for each experimental sample;</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Load the .txt table file in Cluster software;</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Adjust data as following:<OrderedList>
                            <ListItem>
                              <ItemNumber>a.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">Log transform data: replace all data values <Emphasis Type="Italic">X</Emphasis> by log<Subscript>
                                    <Emphasis Type="Italic">2</Emphasis>
                                  </Subscript>
                                  <Emphasis Type="Italic">(X)</Emphasis>. The advantage of transforming the data into log scale is to allow the identification of the magnitude of change between two or more values, irrespectively of the absolute values in the matrix, i.e. the percentage of the considered subset;</Para>
                              </ItemContent>
                            </ListItem>
                            <ListItem>
                              <ItemNumber>b.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">Mean/median center rows and columns: adjust the values of each variable (cell subset/combination of antigens) to reflect their variation from some property of the series of observed values such as the mean or median (identify the distance of each single value to the same reference);</Para>
                              </ItemContent>
                            </ListItem>
                            <ListItem>
                              <ItemNumber>c.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">Normalise rows and columns: set the magnitude of a row/column vector to 1.0</Para>
                              </ItemContent>
                            </ListItem>
                            <ListItem>
                              <ItemNumber>d.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">Filter data: remove values that do not have certain desired properties from you dataset. Note that, when analysing multiple markers at the same time and when performing multiple gates to identify all possible phenotypes, it is likely that some subsets are present at very low frequency, especially when low number of events are acquired. If needed, these subsets can be removed from analysis by filtering the data;</Para>
                              </ItemContent>
                            </ListItem>
                            <ListItem>
                              <ItemNumber>e.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">Hierarchical clustering: cluster rows and columns by choosing the similarity metric and the clustering algorithm;</Para>
                              </ItemContent>
                            </ListItem>
                            <ListItem>
                              <ItemNumber>f.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">On Treeview software, visualise the .cdt file generated by Cluster and analyse the data;</Para>
                              </ItemContent>
                            </ListItem>
                          </OrderedList>
                        </Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
                <Para TextBreak="No">For a more detailed description of Cluster and Treeview softwares, download the manual at <ExternalRef>
                    <RefSource>rana.lbl.gov/manuals/ClusterTreeView.pdf</RefSource>
                    <RefTarget Address="http://rana.lbl.gov/manuals/ClusterTreeView.pdf" TargetType="URL"/>
                  </ExternalRef>. <Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5_4_978-1-60327-527-9">
                    <Emphasis Type="Bold">5.4b</Emphasis>
                  </InternalRef> shows the clustering result of three cohorts of subjects of different age (20, 60 and 100 years) on the basis of the 64 possible cell phenotypes of CD4+ and CD8+ T cells identified by combining the expression of CD45RA, CCR7, CD127, CD95 and CD38 expression <CitationRef CitationID="CR12">(12)</CitationRef>. Note that people with different age can be clustered on the basis of T cell flow cytometric profile. Young individuals go to the left, centenarians to the right, while middle-age donors are scattered between the former two groups.</Para>
              </Section3>
            </Section2>
            <Section2 ID="Sec17" OutputMedium="Online">
              <Heading>General Steps for Optimal Results</Heading>
              <Para TextBreak="No">
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Establish priorities when designing your multicolour experiments. If working with frozen samples and if looking to rare subsets, always save a channel for a dye able to discriminate dead cells; then assign the weakest fluorochromes to lineage markers and the brightest ones to antigens with dull expression.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Include markers with unknown expression patterns in channels, where the spillover from other fluorochromes is minimal, in order to avoid loss of sensitivity after fluorescence compensation.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Start by staining few antigens (3 or 4), then add 1 or 2 antibodies at a time and check whether the initial staining pattern has been modified by the added antibodies. If so, check whether a different staining combination is possible.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Always titrate antibodies and dyes before use and choose the concentration at which the best signal-to-noise ratio is obtained. If performing analysis in fixed/permeabilised samples, antibodies should be titrated by using the same protocol and buffers chosen for the experiment. Different protocols and buffers can have diverse effects on dyes and conjugates and, thus, impact on fluorescent signals and compensation.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
          </Section1>
        </Body>
        <BodyRef FileRef="BodyRef/PDF/978-1-60327-527-9_Chapter_5.pdf" OutputMedium="All" PDFType="Typeset" TargetType="OnlinePDF"/>
        <ChapterBackmatter>
          <Bibliography ID="Bib1">
            <Heading>References</Heading>
            <Citation ID="CR1">
              <CitationNumber>1.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>SP.</Initials>
                  <FamilyName>Perfetto</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>PK.</Initials>
                  <FamilyName>Chattopadhyay</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Roederer</FamilyName>
                </BibAuthorName>
                <Year>2004</Year>
                <ArticleTitle Language="En">Seventeen-colour flow cytometry: unravelling the immune system</ArticleTitle>
                <JournalTitle>Nat Rev Immunol</JournalTitle>
                <VolumeID>4</VolumeID>
                <FirstPage>648</FirstPage>
                <LastPage>55</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD2cXmtFWktrk%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1038/nri1416</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>15286731</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004;4:648–55.</BibUnstructured>
            </Citation>
            <Citation ID="CR2">
              <CitationNumber>2.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>PK.</Initials>
                  <FamilyName>Chattopadhyay</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>DA.</Initials>
                  <FamilyName>Price</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>TF.</Initials>
                  <FamilyName>Harper</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>2006</Year>
                <ArticleTitle Language="En">Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry</ArticleTitle>
                <JournalTitle>Nat Med</JournalTitle>
                <VolumeID>12</VolumeID>
                <FirstPage>972</FirstPage>
                <LastPage>7</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD28Xnsl2itbY%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1038/nm1371</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>16862156</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Chattopadhyay PK, Price DA, Harper TF, et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med 2006;12:972–7.</BibUnstructured>
            </Citation>
            <Citation ID="CR3">
              <CitationNumber>3.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Perfetto</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>D.</Initials>
                  <FamilyName>Ambrozak</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>R.</Initials>
                  <FamilyName>Nguyen</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>PK.</Initials>
                  <FamilyName>Chattopadhyay</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Roederer</FamilyName>
                </BibAuthorName>
                <Year>2006</Year>
                <ArticleTitle Language="En">Quality assurance for polychromatic flow cytometry</ArticleTitle>
                <JournalTitle>Nat. Protocols</JournalTitle>
                <VolumeID>1</VolumeID>
                <FirstPage>1522</FirstPage>
                <LastPage>30</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD28Xht1eitL%2FJ</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1038/nprot.2006.250</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Perfetto S, Ambrozak D, Nguyen R, Chattopadhyay PK, Roederer M. Quality assurance for polychromatic flow cytometry. Nat. Protocols 2006;1:1522–30.</BibUnstructured>
            </Citation>
            <Citation ID="CR4">
              <CitationNumber>4.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>MR.</Initials>
                  <FamilyName>Betts</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>MC.</Initials>
                  <FamilyName>Nason</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>SM.</Initials>
                  <FamilyName>West</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>2006</Year>
                <ArticleTitle Language="En">HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells</ArticleTitle>
                <JournalTitle>Blood</JournalTitle>
                <VolumeID>107</VolumeID>
                <FirstPage>4781</FirstPage>
                <LastPage>9</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD28XlvFCgtrg%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1182/blood-2005-12-4818</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>16467198</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Betts MR, Nason MC, West, SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006;107:4781–9.</BibUnstructured>
            </Citation>
            <Citation ID="CR5">
              <CitationNumber>5.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>N.</Initials>
                  <FamilyName>Baumgarth</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Roederer</FamilyName>
                </BibAuthorName>
                <Year>2000</Year>
                <ArticleTitle Language="En">A practical approach to multicolor flow cytometry for immunophenotyping</ArticleTitle>
                <JournalTitle>J Immunol Methods</JournalTitle>
                <VolumeID>243</VolumeID>
                <FirstPage>77</FirstPage>
                <LastPage>97</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD3cXmtlGlu78%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/S0022-1759(00)00229-5</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>10986408</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Baumgarth N, Roederer, M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 2000;243:77–97.</BibUnstructured>
            </Citation>
            <Citation ID="CR6">
              <CitationNumber>6.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Roederer</FamilyName>
                </BibAuthorName>
                <Year>2001</Year>
                <ArticleTitle Language="En">Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats</ArticleTitle>
                <JournalTitle>Cytometry</JournalTitle>
                <VolumeID>45</VolumeID>
                <FirstPage>194</FirstPage>
                <LastPage>205</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:STN:280:DC%2BD3Mnps1Whuw%3D%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1002/1097-0320(20011101)45:3&lt;194::AID-CYTO1163&gt;3.0.CO;2-C</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>11746088</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 2001;45:194–205.</BibUnstructured>
            </Citation>
            <Citation ID="CR7">
              <CitationNumber>7.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>LA.</Initials>
                  <FamilyName>Herzenberg</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>SC.</Initials>
                  <FamilyName>Rosa</FamilyName>
                  <Particle>De</Particle>
                </BibAuthorName>
                <Year>2000</Year>
                <ArticleTitle Language="En">Monoclonal antibodies and the FACS: complementary tools for immunobiology and medicine</ArticleTitle>
                <JournalTitle>Immunol Today</JournalTitle>
                <VolumeID>21</VolumeID>
                <FirstPage>383</FirstPage>
                <LastPage>90</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD3cXlsVOqsLw%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/S0167-5699(00)01678-9</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>10916141</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Herzenberg LA, De Rosa SC. Monoclonal antibodies and the FACS: complementary tools for immunobiology and medicine. Immunol Today 2000;21:383–90.</BibUnstructured>
            </Citation>
            <Citation ID="CR8">
              <CitationNumber>8.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>F.</Initials>
                  <FamilyName>Sallusto</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>D.</Initials>
                  <FamilyName>Lenig</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>R.</Initials>
                  <FamilyName>Forster</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Lipp</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>A.</Initials>
                  <FamilyName>Lanzavecchia</FamilyName>
                </BibAuthorName>
                <Year>1999</Year>
                <ArticleTitle Language="En">Two subsets of memory T lymphocytes with distinct homing potentials and effector functions</ArticleTitle>
                <JournalTitle>Nature</JournalTitle>
                <VolumeID>401</VolumeID>
                <FirstPage>708</FirstPage>
                <LastPage>12</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DyaK1MXntVWntrw%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1038/44385</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>10537110</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708–12.</BibUnstructured>
            </Citation>
            <Citation ID="CR9">
              <CitationNumber>9.</CitationNumber>
              <BibChapter>
                <BibAuthorName>
                  <Initials>AB.</Initials>
                  <FamilyName>Kantor</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Roederer</FamilyName>
                </BibAuthorName>
                <Year>1997</Year>
                <ChapterTitle Language="En">FACS analysis of leukocytes</ChapterTitle>
                <BibEditorName>
                  <Initials>LA.</Initials>
                  <FamilyName>Herzenberg</FamilyName>
                </BibEditorName>
                <Eds/>
                <BookTitle>Handbook of experimental immunology</BookTitle>
                <PublisherName>Blackwell Science</PublisherName>
                <PublisherLocation>Oxford, UK</PublisherLocation>
                <FirstPage>49.1</FirstPage>
                <LastPage>49.13</LastPage>
              </BibChapter>
              <BibUnstructured>Kantor AB, Roederer M. FACS analysis of leukocytes. In: Herzenberg LA, ed. Handbook of experimental immunology. Oxford, UK: Blackwell Science, 1997:49.1–49.13.</BibUnstructured>
            </Citation>
            <Citation ID="CR10">
              <CitationNumber>10.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>LA.</Initials>
                  <FamilyName>Herzenberg</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>J.</Initials>
                  <FamilyName>Tung</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>WA.</Initials>
                  <FamilyName>Moore</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>DR.</Initials>
                  <FamilyName>Parks</FamilyName>
                </BibAuthorName>
                <Year>2006</Year>
                <ArticleTitle Language="En">Interpreting flow cytometry data: a guide for the perplexed</ArticleTitle>
                <JournalTitle>Nat Immunol</JournalTitle>
                <VolumeID>7</VolumeID>
                <FirstPage>681</FirstPage>
                <LastPage>5</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD28XlvFGjsL4%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1038/ni0706-681</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>16785881</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Herzenberg LA, Tung J, Moore WA, Parks DR. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 2006;7:681–5.</BibUnstructured>
            </Citation>
            <Citation ID="CR11">
              <CitationNumber>11.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Roederer</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>W.</Initials>
                  <FamilyName>Moore</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>A.</Initials>
                  <FamilyName>Treister</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>RR.</Initials>
                  <FamilyName>Hardy</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>LA.</Initials>
                  <FamilyName>Herzenberg</FamilyName>
                </BibAuthorName>
                <Year>2001</Year>
                <ArticleTitle Language="En">Probability binning comparison: a metric for quantitating multivariate distribution differences</ArticleTitle>
                <JournalTitle>Cytometry</JournalTitle>
                <VolumeID>45</VolumeID>
                <FirstPage>47</FirstPage>
                <LastPage>55</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:STN:280:DC%2BD3MrkvFGksA%3D%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1002/1097-0320(20010901)45:1&lt;47::AID-CYTO1143&gt;3.0.CO;2-A</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>11598946</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Roederer M, Moore W, Treister A, Hardy RR, Herzenberg LA. Probability binning comparison: a metric for quantitating multivariate distribution differences. Cytometry 2001;45:47–55.</BibUnstructured>
            </Citation>
            <Citation ID="CR12">
              <CitationNumber>12.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>E.</Initials>
                  <FamilyName>Lugli</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Pinti</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Nasi</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>2007</Year>
                <ArticleTitle Language="En">Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data</ArticleTitle>
                <JournalTitle>Cytometry Part A</JournalTitle>
                <VolumeID>71</VolumeID>
                <FirstPage>334</FirstPage>
                <LastPage>44</LastPage>
                <Occurrence Type="DOI">
                  <Handle>10.1002/cyto.a.20387</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Lugli E, Pinti M, Nasi M, et al. Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytometry Part A 2007;71:334–44.</BibUnstructured>
            </Citation>
          </Bibliography>
        </ChapterBackmatter>
      </Chapter>
    </Book>
  </Series>
</Publisher>
